Avantor's VWR Margin Falls To 9.7% As Faster Growth Brings Lower-Margin Mix

Avantor raised its 2026 outlook, but its distribution unit's operating margin slipped on mix, inflation and investment, executives said.

Share
Avantor's VWR Margin Falls To 9.7% As Faster Growth Brings Lower-Margin Mix

Avantor's VWR distribution business is growing faster than the company's higher-margin product unit, and that is pulling its profitability down: VWR's adjusted operating margin fell to 9.7% in the third quarter, executives said on the company's earnings call Wednesday, as adjusted operating income dropped to $119.4 million from $132.0 million a year earlier.

Mix, then inflation

Avantor, which supplies laboratories and manufacturers through its VWR distribution channel and its own brands such as J.T. Baker chemicals and NuSil silicone, reported $1.698 billion of revenue, up 5.2% organically. VWR organic growth accelerated to 5.8%.

Asked about margins by a Barclays analyst, Steve Eck, the company's senior vice president, chief accounting officer and interim chief financial officer, said mix was "the most significant driver." VWR is about 70% of revenue and grew faster than the bioscience and medtech products segment, which carries a higher margin. Eck said inflation was the next biggest factor, including from "the ongoing conflict in the Middle East."

Company-wide, the picture was steadier. Adjusted EBITDA was $257 million, a 15.1% margin that expanded from the second quarter, and Eck said the trend should continue into the fourth quarter. The bioscience unit's adjusted operating margin was 26.6%, flat from a year earlier.

Pushback on a steeper recovery

A UBS analyst said his model showed VWR's fourth-quarter margin down less than 50 basis points year over year. Chief Financial Officer Todd Garner, on his first call with the company, said Avantor does not guide segment margins and sees no deterioration, and expects margins to rise "modestly" from the third to the fourth quarter.

Chief Executive Officer Emmanuel Ligner said pricing's "number one objective is pricing to offset inflation." Some very large customer contracts let Avantor raise prices at year-end for the following years, he said.

A Jefferies analyst asked whether anything structural would keep VWR from returning to its historical 12% to 13% margin range. Ligner deferred the question to the company's Investor Day on December 8.

Guidance and the balance sheet

Avantor raised its 2026 organic growth outlook to 0.75% to 1.25%. Fourth-quarter organic growth is guided to 2.5% to 4.5%, with VWR growing mid-single digits and bioscience flat to slightly positive on about 400 basis points of discrete headwind.

Adjusted EPS guidance rose to 81 to 83 cents, and free cash flow to $525 million to $550 million. Net debt fell $173 million in the quarter to $3.235 billion, and management said it remains on track to bring leverage below three times by year-end, from 3.1 times.

Ligner said the company will discuss 2027 in February and lay out a long-term financial framework at Investor Day on December 8.

Sources

More on Avantor

All Avantor (AVTR) coverage →